We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 2.86% | 18.00 | 17.50 | 18.50 | 18.00 | 17.50 | 17.50 | 242,114 | 11:30:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2016 15:55 | Given the long-term downward trend, it is crucial that the cholesterol product is backed by a MN like P&G. If not then 40p on the cards. | mazzstar | |
06/12/2016 15:50 | The market isn't buying Opti at present. OHara can talk the talk but has yet to walk the walk. Traders have moved on as volume is non existent. Excellent buy and hold at these levels, as positive news will take this towards 90-100p imho. | john henry | |
06/12/2016 15:09 | Tempted to buy a few, but feel it may have a penny or so to go yet | judijudi | |
06/12/2016 14:42 | Just rangebound as we have been all year Jam tomorrow doesnt cut it with most investors these days Good firm deal making news though, will soon light the touch paper | judijudi | |
06/12/2016 14:32 | When SCAP have shifted the sellers stock then maybe the share price can advance. | john henry | |
06/12/2016 14:32 | Point is we should not be at this price. All the progress that's been made this year is not being recognised by the market. Reason being the constant seller who's been with us for months. They will run out at some point and commercial deals will certainly help them clear! | parob | |
06/12/2016 14:27 | JJ I guess you've noticed the constant 50k sells and being able to buy way under bid (until today) for weeks. | john henry | |
06/12/2016 14:16 | once 60 goes it will be a swift and brutal decent. | loveandmoney1 | |
06/12/2016 14:15 | down she goes expect 40 first stop | loveandmoney1 | |
06/12/2016 14:12 | Institutional invesor selling Funny :) Not even £60k traded in total today! | judijudi | |
06/12/2016 14:04 | Appears to be an Institutional Investor selling once again.Hopefully some positive news in the New Year. | john henry | |
06/12/2016 12:30 | What to sell before it goes any lower. | scotty1 | |
06/12/2016 10:32 | Neft, yes I should have waited. Not concerned as believe we will be over a quid next year at some point. Probably in Q2. | rafboy | |
06/12/2016 10:13 | raftboy, now in the 63's to buy and there we have predictably another 50,000 showing in the 61's | neftanikoff | |
06/12/2016 09:43 | isdx quote is 59/64, there was a late sell yesterday of 50,000, possibly anther one today, hence the drop. | neftanikoff | |
06/12/2016 09:22 | If I could I would but already top heavy in OPTI. Been buying in small batches for some time. | rafboy | |
06/12/2016 09:13 | can you buy some more and round it up to 100,000, tia | neftanikoff | |
06/12/2016 08:41 | Just bought 3819 shares at 64.18p!! | rafboy | |
05/12/2016 20:28 | I think most of us agree Skinbiotix will be a significant kickers for the recovery of the share price, but it will not be the only kicker. SOH has said there is lot to come and he is confidents about the deals. The sugar tax argument is not going away, the government has confirmed its commitment higher tax on high sugar content fizzy drinks, which clearly offers huge scope for our novel sugar IP and strains. No amount of educating people high sugar content and the damage it does will have a positive impact on them if they don't have the willpower. Some will argue it is their choice, so with OPTI novel sugar, they they have the choice with no obesity related issues. IMHO a key area for 2017. | elrico | |
05/12/2016 17:05 | Elrico, you are right we've made our cases. To the relief of most here, I don't have anything else to add for the foreseeable other than I believe the best opportunity for share price turnaround next year will be the skin division. | mazzstar | |
05/12/2016 17:00 | Mazz - Do me a favour stick to facts, please. I have not accused you of anything, I just think we have a different opinion. You state you can read between the lines, great, but like me or anyone, it's guess work open to opinions. So, please stop changing the syntax of my comments, it does you no favours. You have made your case, I have made mine, so let's see how it plays out. No matter whom is right or wrong, it don't need to be turned into a personal attack...I'm sure we have both been wrong before - we survived against all the odds. | elrico | |
05/12/2016 16:38 | A deramping squib? | owenmo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions